Kite Pharma, Inc.
KITE
KITE was delisted on the 2nd of October, 2017.
155 hedge funds and large institutions have $1.84B invested in Kite Pharma, Inc. in 2015 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 71 increasing their positions, 32 reducing their positions, and 27 closing their positions.
122% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 32
30% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 27
24% more capital invested
Capital invested by funds: $1.49B → $1.84B (+$352M)
5% more funds holding
Funds holding: 148 → 155 (+7)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
44% less call options, than puts
Call options by funds: $19.9M | Put options by funds: $35.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$38.6M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$30M |
| 3 |
JP Morgan Chase
New York
|
+$26.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Soros Fund Management
New York
|
-$38.1M |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$7.67M |
| 3 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$6.02M |
| 4 |
CCI
Columbus Circle Investors
|
-$5.88M |
| 5 |
O
OppenheimerFunds
New York
|
-$5.08M |
KITE Hedge Fund Activity: Q2 2015 in Review
155 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q2 2015, worth a combined $1.84B — up 24% from $1.49B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new KITE positions and 27 closed out — a net gain of 8 holders — while 71 added to existing stakes and 32 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $38.6M. The largest seller was Soros Fund Management, exiting entirely with an estimated $38.1M sold.
- 155 institutional investors held Kite Pharma, Inc. (KITE) as of Q2 2015, up from 148 in Q1 2015.
- Funds reported $1.84B of Kite Pharma, Inc. stock for Q2 2015, up 24% quarter-over-quarter.
- 35 funds opened new Kite Pharma, Inc. positions in Q2 2015 and 27 closed out, a net change of +8 holders.
- The largest Kite Pharma, Inc. buyer in Q2 2015 was Viking Global Investors, an estimated $38.6M added.
- The largest Kite Pharma, Inc. seller in Q2 2015 was Soros Fund Management, an estimated $38.1M sold.
Based on aggregated 13F filings for Q2 2015.